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Edited by Hans EklundAbstract Staphylococcus aureus Sav1866 is a bacterial homo-
log of the human ABC transporter Mdr1 that causes multidrug
resistance in cancer cells. We report the crystal structure of
Sav1866 in complex with adenosine-5 0-(b,c-imido)triphosphate
(AMP-PNP) at 3.4 A˚ resolution and compare it with the previ-
ously determined structure of Sav1866 with bound ADP. Besides
diﬀerences in the ATP-binding sites, no signiﬁcant conforma-
tional changes were observed. The results conﬁrm that the
ATP-bound state of multidrug ABC transporters is coupled to
an outward-facing conformation of the transmembrane domains.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Mdr11. Introduction
Multidrug resistance in human cancer cells is mostly the re-
sult of the over-expression of ATP binding cassette (ABC)
transporters that catalyze the extrusion of cytotoxic com-
pounds used in cancer therapy [1]. The members of this inte-
gral membrane protein family translocate diverse substrates
across the membranes of cells and organelles by coupling the
reaction to binding and hydrolysis of adenosine triphosphate
(ATP) [2]. In bacterial cells, ABC transporters are known to
contribute to multidrug and antibiotic resistance by extruding
drugs or antibiotics. In addition, the Lactococcus lactis ABC
exporter LmrA has been found to functionally substitute for
human multidrug resistance 1 gene (Mdr1) when expressed
in lung ﬁbroblast cells [3].
To understand the mechanism of these transport proteins,
we have recently determined the crystal structure of the Staph-
ylococcus aureus multidrug ABC transporter Sav1866 at 3.0 A˚
resolution [4]. Consistent with the predicted, canonical ABC
exporter architecture, Sav1866 comprises two transmembrane
domains (TMDs) that provide a translocation pathway, and
two cytoplasmic, water-exposed nucleotide-binding domainsAbbreviations: Mdr1, multidrug resistance 1 gene; ABC, ATP binding
cassette; TMD, transmembrane domain; NBD, nucleotide binding
domain; AMP-PNP, adenosine-50-(b,c-imido)triphosphate; ADP,
adenosine diphosphate; ATP, adenosine triphosphate; SDS–PAGE,
sodium dodecyl sulfate polyacrylamide electrophoresis
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doi:10.1016/j.febslet.2007.01.073(NBDs) that bind and hydrolyze ATP [2]. Sav1866 is a
homodimeric ABC ‘half-transporter’ with two identical sub-
units each comprising a covalently linked N-terminal TMD
and a C-terminal NBD. The two subunits reveal a considerable
twist and embrace each other, with both the TMDs and NBDs
tightly interacting. Twelve elongated transmembrane helices
form an extrusion cavity in the outward-facing conformation
and provide ‘coupling helices’ at the interface with the NBDs.
Although determined with bound adenosine diphosphate
(ADP), the structure revealed a NBD dimer arrangement
and a conformation consistent with an ATP-bound state, as
observed in the ATP-trapped structures of isolated NBDs
[5,6]. In this head-to-tail arrangement [7,8], two ATP binding
sites are formed at the interface of the NBDs, thus providing
the structural basis of the positive cooperativity in ATP bind-
ing and hydrolysis and a stoichiometry of 2 ATP molecules per
reaction cycle [9,10].
The fact that ADP, rather than ATP, was suﬃcient to induce
the outward-facing conformation of Sav1866 raised the ques-
tion of the physiological relevance of the observed crystal
structure. To address this question, we have determined the
structure of Sav1866 with bound adenosine-5 0-(b,c-imido)tri-
phosphate (AMP-PNP), a non-hydrolyzable analogue of
ATP (see Table 1).2. Materials and methods
2.1. Cloning, expression and puriﬁcation
Staphylococcus aureus Sav1866 was puriﬁed in C12E8 as detergent as
described earlier [4]. The protein was concentrated in 10 mM Tris pH
8.2, 100 mM NaCl to 15 mg/ml using an Amicon Ultra-15 concentra-
tor unit (Millipore) with a molecular cutoﬀ of 100 kDa. Concentrated
protein was analyzed by sodium dodecyl sulfate polyacrylamide elec-
trophoresis (SDS–PAGE) and by gel ﬁltration (size exclusion chroma-
tography) using a Superdex 200 10/300 GL column (GE Healthcare).
2.2. Membrane Reconstitution of puriﬁed Sav1866
Puriﬁed Sav1866 was reconstituted as described earlier for the Esch-
erichia coli vitamin B12 transporter BtuCD [11] and based on previously
developed protocols [12]. In brief, egg yolk L-R-phosphatidylcholine
was mixed with E. coli polar lipid extract at a mass ratio of 1:3. Lipo-
somes were pre-incubated with 0.14% (w/v) Triton X-100 for 1 h at
room temperature. Puriﬁed and concentrated Sav1866 (10 mg/ml)
was supplemented with 0.14% (w/v) Triton X and added to yield a mo-
lar protein to lipid ratio of about 1:50 and the mixture was equilibrated
at room temperature for 2 h with gentle agitation. The ﬁnal lipid con-
centration of the mixture was 4 mg/ml. The detergent was removed
by adding ﬁve consecutive batches of BioBeads SM2 (BioRad), each
batch containing 40 mg BioBeads wet weight per ml solution. After re-
moval of the ﬁnal batch of BioBeads, the turbid suspension was centri-
fuged at 184000 · g for 20 min in a TLA 120.1 rotor and theblished by Elsevier B.V. All rights reserved.
Table 1
Data collection and reﬁnement statistics
Data collection
Space group C2
Unit cell parameters
a, b, c (A˚) 160.961, 104.447, 181.391
a, b, c () 90.000, 98.229, 90.000
Resolution range (A˚) 30–3.4
Rsym or Rmerge
a 9.5 (52.9)
I/rI 13.7 (2.77)
Completeness (%) 100 (100)
Redundancy 5.2 (5.3)
Reﬁnement statistics
Resolution (A˚) 20–3.4
Number of reﬂections (work/test) 38012/2918
Rwork/Rfree 0.2539/0.2776
Number of atoms
Protein 9168
AMP-PNP 62
Na 4
Water 20
B-factors
Protein 124.7
Ligand 77.9
Ion 96.4
Water 73.6
R.m.s deviations
Bond lengths (A˚) 0.0106
Bond angles () 1.5
aHighest resolution shell is shown in parenthesis.
Fig. 1. Biochemical characterization of concentrated Sav1866 protein.
(a) Size exclusion chromatogram of the puriﬁed and concentrated
protein on a superdex 200 10/300 GL size exclusion column (GE
Healthcare). Absorption peaks in the chromatogram represent aggre-
gate species, homodimeric Sav1866, and excess ADP. (b) 12.5% (w/v)
SDS–PAGE of concentrated Sav1866 protein (right lane), with
molecular mass marker proteins in the left lane, and masses indicated
on the left.
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The ﬁnal buﬀer contained 25 mM HEPES, pH 7.5, 150 mM NaCl,
and the ﬁnal lipid concentration was 20 mg/ml. Proteoliposomes were
ﬂash-frozen in liquid nitrogen and stored at 80 C.
2.3. ATPase assays
ATPase activity of puriﬁed Sav1866 in C12E8 detergent was
measured at room temperature as described earlier for BtuCD [11].
The concentration of ATP was 2 mM, and for inhibition, 1 mM
freshly boiled sodium ortho-vanadate was added to the solution.
Inorganic phosphate was assayed by a modiﬁed molybdate protocol
[13].
2.4. Crystallization and structure determination
Sav1866 protein was crystallized in the presence of ADP as
described earlier [4]. Crystals of good quality were selected and incu-
bated for 10 days in a harvesting solution containing 1.3 mM AMP-
PNP to displace ADP. The solution was exchanged after 5 days.
AMP-PNP-bound Sav1866 crystals were cryo-protected in 15% (w/v)
glycerol before ﬂash-freezing in liquid nitrogen. Diﬀraction data were
collected using synchrotron radiation at beamline X06SA of the Swiss
Light Source (SLS) and processed with Denzo and Scalepack [14]. The
structure was solved by molecular replacement using the structure of
Sav1866 [PDB code: 2HYD] as a search model and CNS [15] for the
calculations. Model building was performed using O [16] and the struc-
ture was reﬁned with CNS [15]. Strict twofold non-crystallographic
symmetry was imposed during the reﬁnement except for crystal contact
regions in the extracellular loops and a few residues with evidently dif-
ferent electron density. The structure was reﬁned to 3.4 A˚ resolution
with good reﬁnement statistics (Rwork and Rfree values of 25.39% and
27.76%, respectively) and good geometry. Ramachandran analysis
was performed using Procheck [17], which revealed 85.9% of the resi-
dues in the most favorable, 15.1% in the additional allowed, and no
residues in the generously allowed or disallowed regions. Coordinates
and structure factors of AMP-PNP-bound Sav1866 have been depos-
ited with the Protein Data Bank (PDB code: 2ONJ).3. Results
3.1. Biochemical stability and ATPase activity of SAV1866
Sav1866 was expressed in E. coli, solubilized from mem-
branes, and puriﬁed in detergent in a one-step procedure using
metal aﬃnity chromatography at 4 C. While various ionic,
zwitter-ionic, and non-ionic detergents failed to extract the
protein or caused it to precipitate, functional and homoge-
neous Sav1866 could be puriﬁed in octaoxyethylene-dodecyle-
ther (C12E8). No contaminations were visible on a SDS
polyacrylamide gel (Fig. 1b), indicating high purity of the pro-
tein preparation. Concentration of the protein to 15 mg/ml
caused some aggregation, as evidenced by analytical size exclu-
sion chromatography (Fig. 1a). During the concentration
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ADP than in its absence (not shown).
The basal ATPase activity of Sav1866 was assayed in deter-
gent solution and after reconstitution in proteoliposomes. In
proteoliposomes, the hydrolysis rate was 63 ± 4.7 nmol ATP/
(mg protein min), whereas in C12E8, it increased to
341 ± 6.1 nmol ATP/(mg protein min). The ATPase activity
of Sav1866 was inhibted by ortho-vanadate as was observed
for other ABC transporters. However, addition of 25 lM
AMP-PNP or of 300 lM AMP-PCP did not inhibit the ATP-
ase activity of Sav1866 (not shown). The Km value for ATP
was not determined experimentally, but the amount of ATP
used in the assays (2 mM) is likely signiﬁcantly above the
Km. Km values well below 1 mM have been reported for the
ABC transporters S. typhimurium HisQMP2 (0.6 mM [18]),
B. subtilis YvcC (0.6 mM [19]), and hamster Mdr1 (0.8 mM
[20]).
3.2. Crystal structure of SAV1866 in complex with AMP-PNP
We originally attempted to bind ATP to Sav1866 in the crys-
tals. Addition of ATP did not appear to harm Sav1866 crystals
grown in ADP, and diﬀraction data could be recorded. How-
ever, the electron density maps of such crystals only revealed
ADP at the nucleotide-binding sites (not shown). Presumably,
ATP was hydrolyzed by Sav1866 in the crystals. We therefore
attempted to bind the ATP analogue AMP-PNP, where the
b,c -imido group prevents hydrolysis, to Sav1866 crystals.
AMP-PNP binding was achieved by treating the crystals with
a harvest solutions containing 1.3 mM AMP-PNP for 10 days.
ADP was indeed displaced by AMP-PNP, as evidenced by
clear electron density for the c-phosphate moiety (Fig. 2a,b)Fig. 2. Structure of AMP-PNP-bound Sav1866. (a) Side view and (b) botto
green. Bound AMP-PNP is in ball-and-stick. The red mesh represents a mole
model phases from ADP-bound Sav1866. Clear density is visible for the c-pand extra electron density close to where magnesium or so-
dium ions are observed in high resolution crystal structures
of isolated nucleotide binding domains [5,6]. The binding
mode of AMP-PNP is consistent with that found in the
high-resolution structure of the NBD dimer of Rad50 [5].
A comparison and superposition of the structure of AMP-
PNP-bound Sav1866 with that of ADP-bound Sav1866
revealed a root mean square deviation of 0.097 A˚ for 1116
(of 1156 visible) residues, which demonstrates the high similar-
ity of the two structures. Minor conformational diﬀerences
only exist at the nucleotide binding sites, most notably in the
LSGGQ motifs and the x-loops [4], and at the Gln422 from
the Q-loop. However, because of the limited resolution, these
changes may not be signiﬁcant.4. Discussion
The extrusion of cytotoxic drugs by multidrug ABC trans-
porters is likely facilitated by an alternating access and release
mechanism characterized by at least two distinct conformations
[4,21,22]. In one, a high-aﬃnity binding site for the substrate is
exposed to the cytoplasm, while in the other, a low-aﬃnity bind-
ing site is exposed to the periplasmic or extracellular space
[4,23–25]. The initial structure of Sav1866, determined with
bound ADP, was suggested to reﬂect the ATP-bound state
based on the close structural similarity to the ATP-trapped crys-
tals structures of isolated dimers of NBDs [5,6]. In this state,
Sav1866 revealed a pronounced outward-facing conformation,
with a rather polar cavity exposed to the extracellular medium.
The present structure of Sav1866 with bound AMP-PNPm view of the protein backbone, with the subunits colored yellow and
cular replacement Fo-Fc electron density map at 3.5r calculated using
hosphate moiety of AMP-PNP.
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conformation. We conclude that multidrug ABC transporters
couple the ATP-bound state of the NBDs to an outward-facing
conformation of the TMDs. In vivo, hydrolysis of ATP and re-
lease of ADP and Pi is expected to switch the transporter to an
inward-facing conformation with a high-aﬃnity binding site
accessible from the cell interior [26].
The ﬁnding that ADP is suﬃcient to trigger the ATP-bound
state coupled to an outward-facing conformation suggests that
the conformational equilibrium of Sav1866 is shifted in deter-
gent solution. This is consistent with the observation that addi-
tion of ADP stabilized the protein during the concentration
step preceeding crystallization, as evidenced by size exclusion
chromatography (Fig. 1b). This may indicate that the interac-
tion of ADP with the conserved ATP binding motifs at the
shared interface of the NBDs is suﬃcient to trap the trans-
porter in the ATP-bound state in detergent solution. In the
lipid bilayer, ATP may be needed to trigger the outward-facing
conformation.
In conclusion, the present crystal structure suggests that
Sav1866 couples an ATP-bound state to a drug-releasing, out-
ward-facing conformation. Given the similarity in sequence
and architecture, it is likely that this mechanism may apply
to other multidrug ABC transporters.
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